Aptevo Therapeutics earnings were -$24.1M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest APVO earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$6.3M, up 23.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, APVO reported annual earnings of -$24.1M, with 38.6% growth. The next APVO earnings date is May 6, 2025.
Aptevo Therapeutics Earnings Reports & History FAQ
What were Aptevo Therapeutics's earnings last quarter?
On APVO's earnings call on Invalid Date, Aptevo Therapeutics (NASDAQ: APVO) reported Q4 2024 earnings per share (EPS) of $97.99, up 141.4% year over year. Total APVO earnings for the quarter were -$6.31 million. In the same quarter last year, Aptevo Therapeutics's earnings per share (EPS) was -$236.69.
The next APVO earnings date is Invalid Date. Add APVO to your watchlist to be reminded of Aptevo Therapeutics's next earnings date.
What was APVO's earnings growth in the past year?
As of Aptevo Therapeutics's earnings date in Invalid Date, Aptevo Therapeutics's earnings has grown year over year. APVO earnings in the past year totalled -$24.13 million.
Is Aptevo Therapeutics profitable or losing money?
As of the last Aptevo Therapeutics earnings report, Aptevo Therapeutics is currently losing money. Aptevo Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$24.13 million, a 38.59% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.